-
2
-
-
70350246278
-
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients
-
Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120:1598-1605.
-
(2009)
Circulation
, vol.120
, pp. 1598-1605
-
-
Mazzaglia, G.1
Ambrosioni, E.2
Alacqua, M.3
Filippi, A.4
Sessa, E.5
Immordino, V.6
-
3
-
-
28844455699
-
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: Double-blind, randomised, controlled clinical trial
-
Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005; 366:2005-2011.
-
(2005)
Lancet
, vol.366
, pp. 2005-2011
-
-
Granger, B.B.1
Swedberg, K.2
Ekman, I.3
Granger, C.B.4
Olofsson, B.5
McMurray, J.J.6
-
4
-
-
0025032402
-
Treatment adherence and risk of death after a myocardial infarction
-
Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336:542-545.
-
(1990)
Lancet
, vol.336
, pp. 542-545
-
-
Horwitz, R.I.1
Viscoli, C.M.2
Berkman, L.3
Donaldson, R.M.4
Horwitz, S.M.5
Murray, C.J.6
-
5
-
-
0027293786
-
The relationship of treatment adherence to the risk of death after myocardial infarction in women
-
Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993; 270:742-744.
-
(1993)
JAMA
, vol.270
, pp. 742-744
-
-
Gallagher, E.J.1
Viscoli, C.M.2
Horwitz, R.I.3
-
6
-
-
84880922378
-
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease
-
e7
-
Böhm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, et al. Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease.AmHeart J 2013; 166:306-314; e7.
-
(2013)
Am Heart J
, vol.166
, pp. 306-314
-
-
Böhm, M.1
Schumacher, H.2
Laufs, U.3
Sleight, P.4
Schmieder, R.5
Unger, T.6
-
7
-
-
79951677672
-
Better compliance to antihypertensive medications reduces cardiovascular risk
-
Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 2011; 29:610-618.
-
(2011)
J Hypertens
, vol.29
, pp. 610-618
-
-
Corrao, G.1
Parodi, A.2
Nicotra, F.3
Zambon, A.4
Merlino, L.5
Cesana, G.6
-
9
-
-
44349111871
-
Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories
-
Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336:1114-1117.
-
(2008)
BMJ
, vol.336
, pp. 1114-1117
-
-
Vrijens, B.1
Vincze, G.2
Kristanto, P.3
Urquhart, J.4
Burnier, M.5
-
10
-
-
84907862963
-
Followup of blood-pressure lowering and glucose control in type 2 diabetes
-
Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, et al. Followup of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 2014; 371:1392-1406.
-
(2014)
N Engl J Med
, vol.371
, pp. 1392-1406
-
-
Zoungas, S.1
Chalmers, J.2
Neal, B.3
Billot, L.4
Li, Q.5
Hirakawa, Y.6
-
11
-
-
78650414364
-
Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications
-
Kostis WJ, Thijs L, Richart T, Kostis JB, Staessen JA. Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications. Hypertension 2010; 56:1060-1068.
-
(2010)
Hypertension
, vol.56
, pp. 1060-1068
-
-
Kostis, W.J.1
Thijs, L.2
Richart, T.3
Kostis, J.B.4
Staessen, J.A.5
-
12
-
-
80054737396
-
Long-Term results from statin trials: Answers but more unresolved questions
-
De Backer GG. Long-Term results from statin trials: answers but more unresolved questions. Eur Heart J 2011; 32:2479-2480.
-
(2011)
Eur Heart J
, vol.32
, pp. 2479-2480
-
-
De Backer, G.G.1
-
13
-
-
84863399038
-
Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
-
Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012; 379:1591-1601.
-
(2012)
Lancet
, vol.379
, pp. 1591-1601
-
-
Rothwell, P.M.1
Wilson, M.2
Price, J.F.3
Belch, J.F.4
Meade, T.W.5
Mehta, Z.6
-
14
-
-
53749091595
-
10-year follow-up of intensive glucose control in type 2 diabetes
-
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359:1577-1589.
-
(2008)
N Engl J Med
, vol.359
, pp. 1577-1589
-
-
Holman, R.R.1
Paul, S.K.2
Bethel, M.A.3
Matthews, D.R.4
Neil, H.A.5
-
15
-
-
80054782511
-
Drug discontinuation effects are part of the pharmacology of a drug
-
Reidenberg MM. Drug discontinuation effects are part of the pharmacology of a drug. J Pharmacol Exp Ther 2011; 339:324-328.
-
(2011)
J Pharmacol Exp Ther
, vol.339
, pp. 324-328
-
-
Reidenberg, M.M.1
-
16
-
-
46449116410
-
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program
-
Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol 2008; 52:190-199.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 190-199
-
-
Fonarow, G.C.1
Abraham, W.T.2
Albert, N.M.3
Stough, W.G.4
Gheorghiade, M.5
Greenberg, B.H.6
-
17
-
-
38949209538
-
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome
-
Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008; 299:532-539.
-
(2008)
JAMA
, vol.299
, pp. 532-539
-
-
Ho, P.M.1
Peterson, E.D.2
Wang, L.3
Magid, D.J.4
Fihn, S.D.5
Larsen, G.C.6
-
18
-
-
79960676489
-
Discontinuation of low dose aspirin and risk of myocardial infarction: Casecontrol study in UK primary care
-
Rodriguez LA, Cea-Soriano L, Martin-Merino E, Johansson S. Discontinuation of low dose aspirin and risk of myocardial infarction: casecontrol study in UK primary care. BMJ 2011; 343:d4094.
-
(2011)
BMJ
, vol.343
, pp. d4094
-
-
Rodriguez, L.A.1
Cea-Soriano, L.2
Martin-Merino, E.3
Johansson, S.4
-
19
-
-
84888002406
-
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (Paris): 2 year results from a prospective observational study
-
Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 2013; 382:1714-1722.
-
(2013)
Lancet
, vol.382
, pp. 1714-1722
-
-
Mehran, R.1
Baber, U.2
Steg, P.G.3
Ariti, C.4
Weisz, G.5
Witzenbichler, B.6
-
20
-
-
23944497531
-
Effect of statin use within the first 24 h of admission for acute myocardial infarction on early morbidity and mortality
-
Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al. Effect of statin use within the first 24 h of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005; 96:611-616.
-
(2005)
Am J Cardiol
, vol.96
, pp. 611-616
-
-
Fonarow, G.C.1
Wright, R.S.2
Spencer, F.A.3
Fredrick, P.D.4
Dong, W.5
Every, N.6
-
21
-
-
34548420712
-
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
-
Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370:829-840.
-
(2007)
Lancet
, vol.370
, pp. 829-840
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
Neal, B.4
Woodward, M.5
Billot, L.6
-
23
-
-
84897873247
-
The effect of placebo adherence on reducing cardiovascular mortality: A meta-Analysis
-
Yue Z. Cai C, Ai-Fang Y, Feng-Min T, Li C, Bin W. The effect of placebo adherence on reducing cardiovascular mortality: a meta-Analysis. Clin Res Cardiol 2014; 103:229-235.
-
(2014)
Clin Res Cardiol
, vol.103
, pp. 229-235
-
-
Yue, Z.1
Cai, C.2
Ai-Fang, Y.3
Feng-Min, T.4
Li, C.5
Bin, W.6
-
24
-
-
33745928735
-
A meta-Analysis of the association between adherence to drug therapy and mortality
-
Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-Analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333:15.
-
(2006)
BMJ
, vol.333
, pp. 15
-
-
Simpson, S.H.1
Eurich, D.T.2
Majumdar, S.R.3
Padwal, R.S.4
Tsuyuki, R.T.5
Varney, J.6
-
25
-
-
0030931870
-
Impact of medication nonadherence on coronary heart disease outcomes: A critical review
-
McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes: a critical review. Arch Intern Med 1997; 157:1921-1929.
-
(1997)
Arch Intern Med
, vol.157
, pp. 1921-1929
-
-
McDermott, M.M.1
Schmitt, B.2
Wallner, E.3
-
26
-
-
65449149106
-
Statin adherence and risk of accidents: A cautionary tale
-
Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, et al. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009; 119:2051-2057.
-
(2009)
Circulation
, vol.119
, pp. 2051-2057
-
-
Dormuth, C.R.1
Patrick, A.R.2
Shrank, W.H.3
Wright, J.M.4
Glynn, R.J.5
Sutherland, J.6
-
27
-
-
84878930059
-
Adherence to evidence-based therapies after acute coronary syndrome: A retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain
-
Sanfélix-Gimeno G, Peiró S, Ferreros I, Pérez-Vicente R, Librero J, Catalá-López F, et al. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain. J Manag Care Pharm 2013; 19:247-257.
-
(2013)
J Manag Care Pharm
, vol.19
, pp. 247-257
-
-
Sanfélix-Gimeno, G.1
Peiró, S.2
Ferreros, I.3
Pérez-Vicente, R.4
Librero, J.5
Catalá-López, F.6
-
28
-
-
33645013643
-
Long-Term adherence to evidence-based secondary prevention therapies in coronary artery disease
-
Newby LK, LaPointe NM, Chen AY, Kramer JM, HammillBG, DeLong ER, et al. Long-Term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006; 113:203-212.
-
(2006)
Circulation
, vol.113
, pp. 203-212
-
-
Newby, L.K.1
LaPointe, N.M.2
Chen, A.Y.3
Kramer, J.M.4
Hammill, B.G.5
DeLong, E.R.6
|